Abortion drug RU-486 is quietly killing women across America

July 14, 2011

The Food and Drug Administration (FDA) quietly released a report that details the dangers for women who are considering using Mifepristone, also known as the abortion drug "RU-486." The report states that 14 women have died and more than 2,200 women have experienced serious medical problems from the drug in the United States alone. In addition, the complications of this abortion-inducing drug have led 612 women to be hospitalized, of which 339 were required to undergo a major blood transfusion and 256 suffered from a variety of infections. In spite of serious complications, this drug is continuing to be marketed as "safe" and, according to the Abortion Care Network website, "Many women feel that Mifepristone is private and more natural."

This study also reveals that abortion businesses are misdiagnosing or misusing this drug. In the face of the FDA's warning against prescribing it to "patients with confirmed or suspected ectopic pregnancy," there were 58 cases where it was given to women who had an ectopic pregnancy.

Mifepristone suppresses a woman's immune system. In some cases, fragments of the unborn child or other cells are not entirely expelled from the uterus, causing infection and complications. RU-486 can result in endometritis (an irritation of the lining of the uterus), pelvic inflammatory disease (involving the nearby reproductive organs), and pelvic infections with sepsis (a systemic infection spreading beyond the reproductive organs). The FDA classified 48 of the infections as severe infections, which "generally involve death or hospitalization for at least 2-3 days, intravenous antibiotics for at least 24 hours, [and] total antibiotic usage for at least 3 days..."  the rest